Comparison of Efficacy and Safety of Statin –Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies

ConclusionsStatin –ezetimibe combination therapy enhances levels of LDL-C and other lipids without increasing the risk of adverse events compared with statin monotherapy. The present meta-analysis presents valid evidence for appropriate drug regimens to treat dyslipidemia in patients with diabetes.RegistrationPROSPERO Identifier Number CRD42021244578
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research